Sugi Predict

Sugi Predict / Compounds / SCHEMBL20818972

SCHEMBL20818972

SCHEMBL20818972

COCCNC(=O)c1[nH]c2c(-c3ccccc3)c(C(F)(F)F)nn2c(=O)c1-c1nc2c(OC)cccc2o1

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ NPC1 O15118 1/20 0.35
▸ DGAT1 O75907 2/20 0.34
▸ ALDH1A1 P00352 5/20 0.33
▸ KDM4E B2RXH2 2/20 0.33
▸ TAAR1 Q96RJ0 2/20 0.33
▸ APLNR P35414 1/20 0.33
▸ F2RL3 Q96RI0 1/20 0.33
▸ ADORA2A P29274 1/20 0.33
▸ ADORA1 P30542 1/20 0.33
▸ RAB9A P51151 2/20 0.33
▸ MKNK1 Q9BUB5 1/20 0.33
▸ CYP3A4 P08684 1/20 0.32
▸ HTR3A P46098 1/20 0.32
▸ KCNH2 Q12809 1/20 0.32
▸ GRIN1 Q05586 1/20 0.32
▸ GRIN2B Q13224 1/20 0.32
▸ MEN1 O00255 1/20 0.32
▸ KMT2A Q03164 1/20 0.32
▸ SMN1; SMN2 Q16637 1/20 0.32
▸ HPGD P15428 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20914008 0.94 TAAR1 (0.33) TAAR1F2RL3ADORA2ACYP3A4HTR3A
SCHEMBL20837252 0.92 FYN (0.36) DGAT1ALDH1A1KDM4ETAAR1F2RL3
SCHEMBL20914000 0.92 F2RL3 (0.33) DGAT1F2RL3ADORA2ACYP3A4HTR3A
SCHEMBL20837044 0.91 F2RL3 (0.33) DGAT1F2RL3ADORA2ACYP3A4HTR3A
SCHEMBL20914027 0.90 PTGER1 (0.36) F2RL3ADORA2ACYP3A4HTR3AKCNH2
SCHEMBL20819040 0.89 TNKS (0.35) ALDH1A1KDM4EAPLNRF2RL3ADORA2A
SCHEMBL20913948 0.89 PDE4B (0.35) F2RL3ADORA2AMKNK1CYP3A4HTR3A
SCHEMBL20913950 0.89 PDE4B (0.35) F2RL3ADORA2AMKNK1CYP3A4HTR3A
SCHEMBL20914084 0.88 ADORA2A (0.33) NPC1DGAT1ALDH1A1KDM4EAPLNR
SCHEMBL20913994 0.88 POLB (0.37) ALDH1A1KDM4EF2RL3ADORA2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10738056-B2 Pyrazolopyrimidinone compounds and uses thereof ADURO BIOTECH INC. (US) 2020-08-11 — — US disclosed
US-10738056-B2 Pyrazolopyrimidinone compounds and uses thereof ADURO BIOTECH INC. (US) 2020-08-11 — — US disclosed
EP-3681888-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF Aduro Biotech, Inc. (US) 2020-07-22 — — EP disclosed
US-20190119285-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF CHINOOK THERAPEUTICS, INC. 2019-04-25 — — US disclosed
US-20190119285-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF CHINOOK THERAPEUTICS, INC. 2019-04-25 — — US disclosed
WO-2019055750-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF Aduro Biotech, Inc. (US) 2019-03-21 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10738056-B2 Pyrazolopyrimidinone compounds and uses thereof NLRP3, NLRP1, P2RX7 NPC1 2215/4885DGAT1 4454/4885ALDH1A1 1246/4885
US-20190119285-A1 PYRAZOLOPYRIMIDINONE COMPOUNDS AND USES THEREOF NLRP3, NLRP1, P2RX7 NPC1 2215/4885DGAT1 4454/4885ALDH1A1 1246/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback